InvestorsHub Logo
Post# of 252290
Next 10
Followers 5
Posts 277
Boards Moderated 0
Alias Born 05/29/2011

Re: masterlongevity post# 182249

Monday, 09/29/2014 2:24:57 PM

Monday, September 29, 2014 2:24:57 PM

Post# of 252290
Not sure about the rest of the pipeline but the oncology candidates would have been newsworthy....about 15 years ago. If the rest of the pipeline is also dusted off someone's shelf I would sit this one out.

KD018 was PHY906 (chinese herbal)…increases therapeutic index of chemo by reducing side effects
KD019 was XL647 (EGFR/VEGFR2/HER2 TKI)….3% response rate in EGFR-resistant NSCLC
KD032 was salirasib (salicylic acid derivative)….0% response rate KRAS NSCLC

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.